| Literature DB >> 35566136 |
Zhaohang Zuo1, Shuting Liu1, Weiqiao Pang1, Baoxin Lu1, Wei Sun1, Naidan Zhang1, Xinyu Zhou1, Dongjie Zhang1,2, Ying Wang1,2.
Abstract
Accumulating attention has been focused on resistant starch (RS) due to its blood-lipid-lowering activities. However, reports on the potential bioactivities of RS for preventing hyperlipidemia acute pancreatitis (HLAP) are limited. Therefore, in this study, an acute pancreatitis model was set up by feeding a hyperlipidemia diet to rats, and subsequently evaluating the anti-HLAP effect of RS in kidney beans. The results show that the IL-6, IL-1β, and TNF-α of serum in each RS group were decreased by 18.67-50.00%, 7.92-22.89%, and 8.06-34.04%, respectively, compared with the model group (MOD). In addition, the mRNA expression of tight junction protein ZO-1, occludin, and antibacterial peptides CRAMP and DEFB1 of rats in each RS group increased by 26.43-60.07%, 229.98-279.90%, 75.80-111.20%, and 77.86-109.07%, respectively. The height of the villi in the small intestine and the thickness of the muscle layer of rats were also increased, while the depth of the crypt decreased. The present study indicates that RS relieves intestinal inflammation, inhibits oxidative stress, and prevents related intestinal barrier damage. These results support the supplementation of RS as an effective nutritional intervention for HLAP and associated intestinal injury.Entities:
Keywords: acute pancreatitis; hyperlipidemia; intestinal barrier damage; kidney bean resistant starch
Mesh:
Substances:
Year: 2022 PMID: 35566136 PMCID: PMC9100041 DOI: 10.3390/molecules27092783
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Molecular structure and digestibility of RS. (A) Scanning diagram of the morphology of kidney bean starch (A1) and RS (A2); (B) X-ray diffraction spectra of kidney bean RS (1) and starch (2); (C) size distribution of kidney bean RS and starch; (D) digestive characteristics of kidney bean RS and starch; (E) digestion ratio of kidney bean RS and starch at different times.
Mean particle size of kidney bean starch and resistant starch.
| Sample | Low Particle Size D10/μm | Median Particle Size D50/μm | High Particle Size D90/μm | Volume Average Particle Size/μm | Specific Surface |
|---|---|---|---|---|---|
| Starch | 18.65 ± 0.18 a | 28.77 ± 0.75 a | 40.85 ± 3.54 a | 28.88 ± 1.46 a | 0.119 ± 0.011 a |
| RS | 41.63 ± 0.22 b | 166.30 ± 2.87 b | 355.2 ± 2.12 b | 184.60 ± 3.39 b | 0.044 ± 0.013 b |
Values followed by different lower-case letters in the same column are significantly different from each other (p < 0.05).
Dietary intake of RS affected the body weight and pancreas weight of HLAP rats.
| Parameter | Model Group (MOD) | Control Group (CON) | Simvastatin Group (SV) | Low-Dose RS Group (L-RS) | Medium-Dose RS Group (M-RS) | High-Dose RS Group (H-RS) |
|---|---|---|---|---|---|---|
| Body mass/g | 471.16 ± 8.08 f | 378.73 ± 10.15 a | 405.88 ± 7.19 b | 451.67 ± 6.26 e | 429.78 ± 8.98 d | 418.35 ± 5.19 c |
| Pancreas mass/g | 1.295 ± 0.054 a | 1.789 ± 0.019 f | 1.520 ± 0.023 c | 1.468 ± 0.024 b | 1.666 ± 0.035 d | 1.748 ± 0.041 e |
| Pancreas index/% | 0.289 ± 0.042 a | 0.455 ± 0.041 e | 0.375 ± 0.012 c | 0.325 ± 0.010 b | 0.388 ± 0.016 cd | 0.418 ± 0.014 d |
Values followed by different lower-case letters in the same line are significantly different from each other (p < 0.05).
Blood-serum-related parameter levels in each group of rats.
| Parameter | MOD | CON | SV | L-RS | M-RS | H-RS |
|---|---|---|---|---|---|---|
| TC (mmol/L) | 4.08 ± 0.13 e | 0.81 ± 0.14 a | 2.44 ± 0.11 d | 2.32 ± 0.21 d | 1.55 ± 0.17 c | 1.25 ± 0.14 b |
| TG (mmol/L) | 2.22 ± 0.12 f | 0.67 ± 0.05 a | 1.48 ± 0.07 c | 1.94 ± 0.13 e | 1.74 ± 0.05 d | 1.25 ± 0.08 b |
| AMLY (U/L) | 4366.16 ± 117.84 f | 1280.27 ± 71.93 a | 2660.19 ± 105.55 b | 3637.9 ± 61.05 e | 3218.61 ± 60.65 d | 3010.32 ± 65.86 c |
| LIPA (U/L) | 1016.58 ± 35.73 e | 107.97 ± 19.91 a | 780.51 ± 20.57 d | 793.22 ± 15.39 d | 674.44 ± 32.76 c | 523.05 ± 27.66 b |
| TNF-α (pg/mL) | 197.60 ± 2.72 f | 60.13 ± 4.10 a | 110.60 ± 2.37 b | 181.67 ± 3.25 e | 140.67 ± 4.39 d | 130.33 ± 4.29 c |
| IL-6 (pg/mL) | 110.67 ± 4.59 d | 12.33 ± 1.53 a | 50.67 ± 3.61 bc | 90.00 ± 2.00 c | 75.33 ± 4.18 b | 55.33 ± 2.07 b |
| IL-1β (pg/mL) | 86.88 ± 2.46 f | 15.00 ± 1.43 a | 53.80 ± 0.82 b | 80.00 ± 1.26 e | 72.82 ± 1.81 d | 67.00 ± 2.03 c |
| DAO (ng/mL) | 95.07 ± 4.21 e | 57.58 ± 3.51 a | 70.51 ± 1.41 b | 85.98 ± 3.32 d | 72.13 ± 4.96 bc | 75.31 ± 2.31 c |
| DLA (μmol/L) | 38.76 ± 2.27 f | 23.57 ± 0.62 a | 26.72 ± 1.34 b | 36.76 ± 1.05 e | 35.08 ± 1.14 d | 28.41 ± 0.92 c |
| ET (EU/mL) | 71.84 ± 1.87 e | 53.16 ± 2.58 a | 57.26 ± 1.82 c | 67.74 ± 1.12 d | 56.37 ± 1.70 bc | 54.84 ± 2.27 ab |
| sIgA (μg/mL) | 19.01 ± 0.73 a | 25.04 ± 1.16 c | 26.75 ± 1.75 d | 19.49 ± 0.78 a | 21.28 ± 1.39 b | 22.67 ± 1.38 b |
Values followed by different lower-case letters in the same line are significantly different from each other (p < 0.05).
Figure 2The degree of pancreatic edema on rats (A) and MPO activity in pancreatic tissues of rats (B) in each group (ns p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 versus MOD, and the points of different shapes represent the actual value of each sample, n = 6).
Figure 3HE staining observation of rat pancreas pathology (×100). (A) CON; (B) MOD; (C) SV; (D) L-RS; (E) M-RS; (F) H-RS.
Figure 4HE staining of the small intestine in each group of rats (×100). (A) CON; (B) MOD; (C) SV; (D) L-RS; (E) M-RS; (F) H-RS.
Figure 5Effect of kidney bean RS on ZO-1 (A), occludin (B), CRAMP (C), and DEFB1 (D) gene expression in rat intestine (** p < 0.01; *** p < 0.001; **** p < 0.0001 versus MOD, and the points of different shapes represent the actual value of each sample, n = 6).
The feed composition of rats in each group.
| Ingredients (%) | CON | MOD | SV | L-RS | M-RS | H-RS |
|---|---|---|---|---|---|---|
| Corn starch | 73.5 | 53.51 | 53.51 | 53.51 | 53.51 | 53.51 |
| Wheat bran | 20 | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 |
| Fish meal | 5 | 3.6 | 3.6 | 3.6 | 3.6 | 3.6 |
| Farina | 1 | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 |
| Sodium salt | 0.5 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 |
| Cholesterol | / | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| Egg yolk powder | / | 5.8 | 5.8 | 5.8 | 5.8 | 5.8 |
| Sucrose | / | 10 | 10 | 10 | 10 | 10 |
| Lard | / | 10 | 10 | 10 | 10 | 10 |
The gene sequence of each primer.
| Gene Name | Forward Primer | Temperature/°C | Length/bp |
|---|---|---|---|
| ZO-1 | GAGATGAGCGGGCTACCTTA | 57.2 | 210 |
| Occludin | TGGGACAGAGCCTATGGAAC | 57.2 | 197 |
| CRAMP | TCACTGTCACTGCTATTGCTCCT | 59.3 | 208 |
| DEFB1 | CTGCCCATCTCATACCAAACTAC | 58.4 | 112 |